The anti-epileptic drugs market has experienced steady growth, propelled by factors such as the increasing prevalence of epilepsy, growing awareness about available treatment options, and advancements in drug research and development. According to recent studies, epilepsy affects approximately 50 million people globally, with nearly 2.4 million new cases diagnosed every year.